A positive correlation between sorafenib resistance and ALYREF protein expression, and a negative correlation between sorafenib resistance and NR3C2 or SORBS2 protein expression was obtained in our HCC cohort (Figures 7I, J), further supporting the relevance of the hub genes to sorafenib resistance in HCC. This evidence concerns the gene ALYREF and hepatocellular carcinoma.